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ABSTRACT 
The Determinants of Colorectal Cancer Survival Disparities 
in Nevada 
 
by 
Lucas Nyamanda Wassira 
Dr. Paulo Pinheiro, Examination Committee Chair 
Assistant Professor, Epidemiology 
University of Nevada, Las Vegas 
 
Different population groups across Nevada and throughout 
the United States suffer disproportionately from colorectal 
cancer and its after-effects. Overcoming cancer health 
disparities is important for lessening the burden of 
cancer. There has been an overall decline in the incidence 
of and mortality from colorectal cancer (CRC). This is 
likely due, in part, to the increasing use of screening 
procedures such as Fecal Occult Blood Test (FOBT) and/or 
endoscopy, which can reduce the risk of CRC mortality by 
fifty percent. Nevertheless, screening procedures are 
routinely used by only fifty percent of Americans aged 
fifty years and older. Despite overall mortality decreasing 
over time, there continues to be a widening disparity in 
CRC incidence and survival between races and ethnicities. 
To assess CRC survival disparities across race and 
ethnicity in Nevada, data from the statewide Nevada Central 
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Cancer Registry (NCCR) was used. We examined a cohort of 
men and women [n=11,459] who were diagnosed with CRC from 
1995 through 2006 in Nevada. Cause-specific survival 
analyses were performed to ascertain the determinants of 
CRC disparities. Hazard ratios were calculated and 
stratified by race/ethnicity groups. The five years age 
adjusted survival rates were compared for 1995 – 1998, and 
1999 - 2001. In the univariate model type three tests 
(Wald=24.71, df=5, p=.0002), race/ethnicity was 
statistically significant implying that there are survival 
disparities between race/ethnicity groups. African 
Americans had 20.6% risk ratio of CRC death in relation to 
Whites [HR = 1.21, 95% CI=1.05 – 1.39]. However, after 
adjusting for gender, age groups, health insurance type, 
period of diagnosis, stage of diagnosis, and sub-location 
within the colon and rectum in a multivariate analysis,  
Blacks and Hispanics  had an increased risk of death in 
relation to Whites  [HR = 1.24, p=0.004 for Blacks, and 
Hispanics HR=1.12, p=0.04] . More aggressive screening and 
equal treatment opportunities would do much to remedy the 
survival disparity seen among race/ethnic groups. 
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CHAPTER 1 
INTRODUCTION 
Colorectal carcinoma (CRC) is the cancer that forms in 
the tissues of the colon or rectum.  Cancers of the colon 
or rectum have many features in common and are discussed 
together in this project.  
Altekruse et al. (2010) on their cancer statistic review 
published on the Surveillance Epidemiology and End Results 
Program (SEER), it was identified that CRC is the second 
deadliest cancer, and third most commonly diagnosed cancer 
in the United States. For the year 2010, Altekruse et al., 
estimated 142,570 new cases in the United States (72,090 in 
men and 70,480 in women) would be diagnosed with and 51,370 
would die of CRC.  
In a cancer statistics report by Murray et al. (2003), 
the authors reported CRC accounts for ten percent of annual 
cancer-related deaths in the United States.  
Between 2002 and 2006, Nevada had an annual age-adjusted 
incidence rate of 49.1 per 100,000 (C.I = 47.7 - 50.4) 
versus 50.4 [C.I = 50.3 - 50.5] per 100,000 men and women 
for the whole United States (Altekruse et al., 2010). The 
authors also reported an annual age-adjusted mortality rate 
of 19.6 [C.I = 18.7 – 20.5] per 100,000 person-years for 
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Nevada versus 18.2 [C.I = 18.1 – 18.3] per 100,000 person-
years for the whole United States in the same period [table 
1 and 2].  
 
Table 1: Colon and Rectum Age Adjusted Incidence Rates and 
95% Confidence Intervals. Nevada and United States 2002 – 
2006 
Geographic 
Area All Races White Black Hispanic* 
United 
States 
50.4 
C.I = 50.3 - 
50.5 
49.5 
C.I = 49.4 - 
49.6 
58.1 
C.I = 57.6 - 
58.5 
41.6 
C.I = 41.2 - 
42.0 
Nevada 
49.1 
C.I = 47.7 - 
50.4 
49.3 
C.I = 47.9 - 
50.8 
51.7 
C.I = 46.0 - 
57.8 
39.8 
C.I = 35.6 - 
44.3 
 
 
Table 2: Colon and Rectum Age Adjusted Death Rates and 95% 
Confidence Intervals. Nevada and United States 2002 – 2006 
Geographic 
Area All Races White Black Hispanic* 
United 
States 
18.2 
C.I = 18.1-
18.3 
17.7 
C.I = 17.6-
17.7 
25.4 
C.I = 25.1-
25.7 
13.0 
C.I = 12.8-
13.3 
Nevada 
19.6 
C.I = 18.7-
20.5 
20.0 
C.I = 19.1-
21.0 
21.3 
C.I = 17.5-
25.5 
10.5 
C.I = 8.3-
13.1 
 
Note: 
• (*) Hispanic origin is not mutually exclusive from category race 
(white, black) 
• Rates are per 100,000 persons. 
• Source(U.S. Cancer Statistics Working Group, 2010) 
 
Based on rates from 2005-2007 (Altekruse et al., 2010), 
the authors noted that 5.12% of men and women born today 
will be diagnosed with CRC at some time during their 
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lifetime.  Meaning, 1 in 20 men and women will be diagnosed 
with CRC during their lifetime.  When looking at the 
probability of developing CRC between genders for the same 
age periods, Altekruse et al. reported 2.04 percent of men 
compared to 1.53 percent of women will develop cancer of 
the colon and rectum between their 50th and 70th birthdays.  
For survival, Altekruse et al. (2010) reported that 
overall 5-year CRC relative survival for 1999-2006 from 17 
SEER geographic areas was 65.0%. Five-year relative 
survival by race and sex was: 66.0% for white men; 65.7% 
for white women; 55.6% for black men; 56.6% for black 
women.  
The study of cancer health disparities has been 
documented in many populations and cancer types. The causes 
of these inequalities are not well understood but may 
include disease and patient characteristics, treatment 
differences and health service factors. CRC health 
disparities are differences in the incidence, prevalence, 
mortality, and survival of adverse health conditions, in 
the context of disenfranchised segments of the population. 
Understanding these disparities is a potential public 
health component for intervention towards lessening CRC 
burden. 
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There are striking differences between racial and ethnic 
groups in both mortality and survival for colorectal cancer 
in Nevada and the United States in general.  As many 
population groups across Nevada and around the United 
States suffer disproportionately from CRC and its after-
effects, overcoming CRC health disparities is of ut-most 
significance.  
The reasons for disparity in survival have not been 
elucidated and may include many factors such as differences 
in access to preventive medical care, as well as quality 
and type of care received after diagnosis.  
The purpose of this study was to ascertain the 
determinants of colorectal cancer survival disparities that 
exist in selected populations of Nevada, and ultimately 
suggest ways to minimize those disparities. Secondary 
objectives includes: 1) To quantify the effects of CRC 
stage of diagnosis, gender, type of health insurance, and 
colorectal sub-location on CRC racial/ethnic survival 
disparities, and 2) To assess change in CRC survival over 
time by race/ethnicity stratified by age and stage of 
diagnosis,  
Findings of the study were used to answer the research 
question, what are the determinants of colorectal cancer 
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survival disparities among Nevadans? Further, in answering 
this question it was hypothesized that:  1) Blacks will 
have lower 5-year age-adjusted survival rates than non-
Hispanic whites, 2) Increasingly advanced stage will be 
inversely associated with survival 3) Increasing age will 
be inversely associated with survival 4) Blacks will have a 
higher relative risk of death compared to Whites and  5) 
CRC patients on Medicaid and those with lack of health 
insurance will have/show a higher relative risk of death 
compared to CRC patients on private insurance.  
Data from the Nevada Central Cancer Registry (NCCR) was 
used for the study. NCCR is the population-based registry 
that collects and maintains data on all cancer patients 
within the State of Nevada. The Registry began collecting 
cancer incidence data in 1989, and continues to collect 
data on all reportable cancers in accordance with the 
National Program for Cancer Registries (NPCR) and the North 
American Association of Central Cancer Registries (NAACCR) 
Standards. The study population was all Nevada residents 
who were diagnosed with CRC from 1995-2006, with follow up 
through December 31, 2006, and registered in the Nevada 
Central Cancer Registry. 
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CHAPTER 2 
LITERATURE REVIEW 
There has been reported overall decline in the incidence 
of and mortality from CRC (Espey et al., 2007). This is 
likely due, in part, to the increasing use of screening 
procedures such as Fecal Occult Blood Test (FOBT) and/or 
endoscopy, which can reduce the risk of CRC mortality by 50 
percent (Walsh, 2004). However, screening procedures are 
routinely used by only 50 percent of Americans age 50 years 
or older.  
Despite overall incidence and mortality decrease over 
time (U.S Cancer Statistics, 2010), Irby (2006) found a 
continue widening disparity in CRC survival between races 
and ethnicities. For the year 2002 – 2006, United States 
Cancer Statistics (2010) reported the age-adjusted death 
rate per 100,000 in Nevada males was 26.2 (C.I = 19.8-33.8) 
in Blacks compared with 23.6 (C.I = 22.2-25.2) in Whites 
and 13.1 (C.I = 9.2-17.8) in Hispanics. For females, the 
death rate was 17.7 (13.3-23.0) in Blacks compared with 
16.8 (C.I = 15.6-18.0) in Whites and 8.9 (C.I = 6.2-12.1) 
in Hispanics. 
In the same 2002-2006 period, according to the American 
Cancer Society (2007), stage-specific survival rates were 
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96%, 87%, 55%, and 5% for CRC stages: In Situ, Local, 
Regional, and Distant, respectively. When CRC is detected 
at an early localized stage, the five-year relative 
survival rate is 90%; however, only 39% of CRC’s are 
discovered at this stage (ACS, 2007).  
Rabeneck et al. (2003) found that overall and stage-
specific five year CRC survival rates were higher for 
Whites compared with African Americans, and differences 
were largely attributable to the stage of disease at 
diagnosis. 
In another study by Mostafa et al. (2004), the authors 
found that African Americans tended to present with an 
advanced disease stage and having a poorer clinical outcome 
than do Whites. Other studies, however, have shown that 
even with a similar distribution of tumor stage by race or 
after statistical adjustment for stage, survival 
disparities between African Americans and Whites persisted 
(Govindarajan et al., 2003).  
Moreover, Marcella and Miller (2001) found CRC survival 
disparity among race and ethnicity groups remained even 
after controlling for socioeconomic, comorbid, and 
treatment factors. 
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In a study about SES impact on CRC survival, Marcella and 
Miller (2001) also found that SES differences explained a 
large portion of the racial disparity in CRC survival. 
Nevertheless, in a meta-analysis of SES influences on CRC 
survival racial differences, Du et al. (2007) demonstrated 
that after adjusting for SES, no significant survival 
disparity was observed.  
Among patients with CRC, Bach (2002) and Mostafa (2004) 
found that Blacks had higher death rates than Whites, even 
when stage of cancer is controlled for.  
Banerjee et al. (2009) in their study on the effect of 
demographics, clinical factors, and socioeconomic status on 
CRC racial disparities, they found African Americans had a 
significantly increased risk of death (HR, 1.13; 95% CI, 
1.07-1.20) from CRC as compared to Whites. However, when 
simultaneously adjusted for age, sex, marital status, SES, 
tumor grade, SEER stage, and surgical treatment in a 
multivariate model, race was no longer significantly 
associated with survival (HR, 1.00; 95% CI, 0.92-1.09). 
 Conversely, in many other studies (Mayberry, 1995), 
stage of diagnosis was consistently shown to be the 
strongest predictor of excess risk of death for CRC 
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patients accounting for greater than 50% of the excess 
mortality. 
 Further, Banerjee et al. (2009) found the 
determinants: increasing age at diagnosis, tumor grade, 
marital status, and treatment disparity are significantly 
associated with decreased survival among individuals with 
colorectal cancer. 
 In a Danish study by Johansen et al. (1998), being 
married was found to have a positive influence on survival 
among CRC patients. 
In the studies by Ward (2008) and Ayanian (1993), the 
authors found that patients diagnosed with colorectal 
cancer who were either uninsured or on Medicaid had worse 
survival than patients with private health insurance. 
Cardinez et al. (2004) identified income, education, and 
health insurance coverage influences access to appropriate 
early detection, treatment, and palliative care for CRC. 
 In the studies of screening and CRC, other studies have 
found being Blacks is associated with a lower screening 
rate for CRC. Additionally, Etzioni et al. (2006) found 
that screening disparity exists amongst Blacks and Whites 
with positive family history. 
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Similarly, James et al. (2002) in their study about the 
relationship of perception to screening behavior, the 
authors found that African-Americans’ perceptions of 
sigmoidoscopy and colonoscopy differ from fecal occult 
blood testing (FOBT) with respect to perceived benefits 
versus barriers. Specifically, the authors found barriers 
were significantly and negatively associated with FOBT and 
sigmoidoscopy. However, in the same study the authors found 
a significant positive association between perceived 
benefits and sigmoidoscopy or colonoscopy but not with 
FOBT.  
Higher educational status and greater knowledge of 
flexible sigmoidoscopy were found to predict greater 
adherence to screening flexible sigmoidoscopy guidelines 
(Lawsin, 2007); whereas, greater knowledge of FOBT and 
doctor recommendation predicted greater adherence to FOBT 
screening guidelines in an East Harlem Blacks population 
(Lawsin et al., 2007). 
Schroy et al. (2008) found knowledge status about 
colorectal cancer is lower in African Americans than in 
Whites. In addition, Schroy et al. also found that African 
Americans who adhered to the screening guidelines were 
tended to be more knowledgeable about colorectal cancer and 
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held more positive beliefs about the benefits of screening 
than those who were not up-to-date with screening. 
In another study by Peterson et al. (2008), the authors 
found having either a screening sigmoidoscopy or 
colonoscopy is positively associated with education status, 
being married, higher household income, recent medical 
visit, higher age, and public or private insurance among 
Blacks. 
Mayberry et al. (1995), on the other hand, found the risk 
of death from invasive CRC among Blacks patients was fifty 
percent higher than among Whites patients [HR = 1.5 (95% CI 
= 1.2 - 1.9)]. However, after adjustment for age, sex, and 
location, in that particular study, subsequent analyses 
with all potential explanatory variables in the model did 
not show any significant interactions of race separately 
with age, sex, location, and poverty index. 
 Additionally, Mayberry et al. (1995) also found Blacks 
were more likely than Whites to be diagnosed with advanced 
disease. After adjustment for stage, however, the disparity 
diminished. There was no racial difference in survival for 
patients with distant stage metastatic disease.  
In the study describing racial and ethnic patterns of 
cancer-specific survival and relative risks (RRs) of cancer 
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death, Clegg et al. (2002) found survival rates improved 
between 1988 and 1997 for virtually all racial and ethnic 
groups. However, racial or ethnic differences in RRs of 
cancer death persisted after controlling for age for all 
cancers combined and for age and stage for specific cancer 
sites (P<.01). Additionally, it was also found that Blacks, 
American-Indian, Alaskan-Native, and Hawaiian-Native 
patients tended to have higher RRs of cancer death than the 
Whites. American-Indians and Alaskan-Natives generally 
exhibited the highest RRs of cancer death, except for 
colorectal cancer in males. 
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CHAPTER 3 
METHODOLOGY 
Study Population 
The study population in this study comprised men and 
women diagnosed with a first primary colon or 
rectal/rectosigmoid junction carcinoma from 1995 through 
2006, identified through the Nevada Central Cancer Registry 
(NCCR) and followed for vital status until December, 31st 
2006.  
Data Sources 
Cancer incidence statistics were obtained from (NCCR) 
through the Bureau of Health Planning and Statistics. Death 
records came from the Office of Vital Records (OVR), also 
within the Bureau of Health Planning and Statistics. CRC 
cause of death was classified based on ICD-9 for all deaths 
which occurred on and before 1998 and ICD-10 for deaths 
after 2000. 
CRC Classification 
CRC cancer site and morphology were coded according to 
the International Classification of Diseases for Oncology 
(ICD-O) coding structure codes C18.0-20.9(WHO, 1990) that 
includes topography as well as morphology. Cancers with 
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histologic codes 9590 through 9989 which include intestinal 
lymphomas were excluded (Ries, 2000). 
CRC Stage of Diagnosis Classification 
Surveillance Epidemiology and End Results Program (SEER) 
summary staging (localized, regional, and distant) was used 
to categorize the extent of the disease. 
Statistical Techniques 
Variables determined at diagnosis that were assessed for 
prognostic significance for survival included age, gender, 
stage (SEER), payer, race and ethnicity, CRC sub-location, 
and time period of diagnosis. 
Statistical analyses were carried out using likelihood 
ratio chi-square tests to compare the demographics, stage 
of diagnosis and accessibility to healthcare for race and 
ethnicity groups. G-statistic P-values less than .05 were 
considered statistically significant.  
Survival rates were calculated using the actuarial 
method. Partial likelihood tests were used to estimate the 
regression coefficients. Test statistic results were 
reported using Wald test value and Wald Chi-square p-
values.  
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Cox Proportional Regression Modeling 
A univariate model was first performed to assess the 
impact of race/ethnicity alone on CRC survival. A 
multivariable model was executed next to account for other 
covariates in the model. 
In the multivariable model, adjusted hazard ratios (HR) 
and their corresponding 95 percent confidence intervals 
(CI) were estimated using the Cox proportional hazards 
regression. To assess independent prognostic importance, 
each factor included in the model was tested for 
significance based on the Wald Chi-square test 
incorporating the appropriate degrees of freedom.  
Additionally, for each factor, subgroup level hazard ratios 
were estimated and corresponding Wald Chi-square p-values 
were reported. 
CRC Survival 
Cancer-specific survival was defined as the time between 
the date of diagnosis and either the date of death due to 
CRC or the last follow-up date whichever occurred first. 
The cause-specific survival rate, which estimates the 
likelihood of surviving cancer during a specified time 
period if CRC is the only cause of death, was used for this 
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study (Clegg et al., 2002). Survival time was calculated in 
years. Patients who died of causes other than the CRC or of 
unknown causes prior to the cut-off follow-up date of 
31December2006 were censored at time of death. All others, 
if not dead by CRC or if alive after December 31 2006 were 
censored at the date of last linkage with the State Vital 
Statistics up until the cutoff date of December 31, 2006.  
Age Categorization 
Age at diagnosis was categorized into the following 5 
categories: <44, 45-54, 55 – 64, 65 – 74, and ≥75 years 
old.  
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CHAPTER 4 
RESULTS 
A total of 11,459 diagnoses of CRC from 1995 through 2006 
were included in the study. Of those diagnoses, 53.6 
percent [n=6139] were male and the remaining 46.4 percent 
[n=5320] were female. Whites made up the largest proportion 
of the patients in Nevada, constituting 83.9 percent 
[n=9610]. Other racial-ethnic groups included Blacks 5.6 
percent [n=644], Asian 3.3 percent [n=378], and Hispanics 
5.9 percent [n=662].  
For the period 1995 through 2006, the mean age for colon 
and rectum diagnoses in Nevada for both gender and 
race/ethnicity was 68 years with a standard deviation of 
12.5. The minimum age of diagnosis was 11 and maximum age 
was 103. Most people, 35.5 percent, were diagnosed at the 
regional stage. 30.6 percent were diagnosed at localized 
stage, 17.9 percent at distant stage, and 13.2 percent 
diagnoses were unstaged.  
Of 11,459 CRC diagnoses, 24.1 percent of the patients had 
private health insurance at the time of diagnosis. 11.9% 
had Medicare, 5.2% were on Medicaid, and 4.8% were 
uninsured. The largest proportion of patients, 54.1%, had 
unknown health insurance at the time of their diagnosis. 
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Table 3: Patients’ Demographic and Clinical Characteristics by 
Race/Ethnicity [n = 11,294]. 
Characteristic White 
N =9610  
Black 
N =644  
Asian 
N =378  
Hispanic 
N = 662 
P-
value* 
Age at diagnosis     <.0001 
<44 3.5 5.3 7.1 9.1  
45 – 54 9.1 16.8 17.5 15.9  
55 – 64 19.7 28.6 23.5 24.5  
65 – 74 31.7 28.4 29.1 27.2  
75+ 36.0 21.0 22.6 23.4  
Gender     0.004 
Male 53.9 53.3 44.4 53.6  
Female 46.1 46.7 55.6 46.4  
Stage of 
Diagnosis 
    0.07 
Local 31.1 27.8 25.4 28.6 
 
 
Regional 35.7 34.8 38.9 34.6  
Distant 17.5 21.6 19.8 21.0  
Unstaged 13.2 13.0 12.4 12.8  
Payer at 
Diagnosis 
    <.0001 
Medicare 11.5 9.3 9.0 7.1  
Medicaid 2.3 6.2 5.3 5.6  
Private 26.1 32.6 35.2 35.6  
Uninsured 4.5 7.0 6.1 7.3  
Unknown 55.6 44.9 44.44 44.41  
Tumor sub-
location 
    <.0001 
Proximal 40.6 49.8 33.6 32.9  
Sigmoid Colon 20.6 20.2 27.0 25.8  
Rectosigmoid and 
Rectum 
27.8 18.2 28.4 30.8  
Colon NOS 11.1 11.8 10.6 10.4  
*Likelihood ratio chi-square p-value 
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There were 5,514 (48.1%) deaths in Nevada for the period 
1995 – 2006; 3,388 (29.6%) deaths occurred due to 
colorectal cancer.  
Demographically, Blacks, Asians, and Hispanics were more 
likely than Whites to be diagnosed at a younger age, 16.8 
percent, 15.9 percent, and 17.5 percent respectively versus 
9.1 percent for Whites. Blacks were more likely to be 
uninsured than other races/ethnicity. 
With regard to clinical variables, Blacks were more 
likely than White to present with distant stage disease at 
the time of diagnosis, 21.6 percent versus 17.5 percent for 
Whites. Asians were diagnosed at a distant stage in 19.8 
percent, and Hispanics 21.0 percent. 
Survival Analyses 
In this particular study, it was found the median overall 
survival for the entire cohort was 5.4 years with a 5-year 
survival rate of 53.4 percent. For CRC cause-specific 
survival, the unadjusted analysis showed that Blacks 
patients had a significantly increased risk of death for 
CRC (HR = 1.21, CI = 1.05 – 1.39, p=0.009) compared with 
White patients (Table 4). The model was significant with a 
Wald Chi-square statistic value of 24.71, p = .0002. 
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Table 4: Univariate Survival Analysis Results to Assess 
Individual Prognostic Importance 
Analysis of Maximum Likelihood Estimates 
Parameter HR 
95% C.I of the HR 
P-
value LL UL 
Ref = White 1    
Blacks 1.206 1.047 1.390 0.0094 
Hispanic 1.060 0.916 1.227 0.4313 
Asian 1.005 0.825 1.225 0.9601 
 
                Type 3 Tests 
                          Wald 
Effect        DF    Chi-Square    ChiSq p-value 
race_eth       5       24.7050        0.0002 
 
Note 
LL = Lower Limit 
UL = Upper Limit 
HR = Hazard Ratio 
 
 
 
Conversely, in the multivariate model (Table 5) when 
simultaneously adjusted for age group, gender, SEER stage, 
health insurance type, period of diagnosis, sub location of 
the tumor, race and ethnicity was significantly associated 
with increased risk of death(p = 0.0001). For Blacks and 
Hispanics compared to Whites it was estimated that the 
increase in risk of death was 22%, and 15% respectively. 
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Patients in age group 75 years and above had higher 
increased hazards of death (HR=2.1) as opposed to the 
younger group, less than age 44. Also, age groups 55 – 64, 
and 65 – 74 (HR = 1.25, and 1.41) respectively had 
increased hazards of death in relation to those less than 
44 years old.  
Additionally, we also found in the study female patients 
had better survival than males, with an 8.4 percent 
decreased risk of death [HR = 0.92]. 
Using localized Stage as the reference group, patients 
diagnosed in regional, distant and unstaged CRC had 
increased risks of death compared with those diagnosed in 
localized stage. Compared with localized stage, patients 
diagnosed in regional stage had HR of 2.75   with 95 percent 
C.Is of 2.42 and 3.12. Distant stage conveyed HR of 10.98, 
with 95% C.Is of 9.66 – 12.47 in relation to the localized 
stage. 
This study also found Blacks had lower 5-year age 
adjusted survival rates than White when compared across two 
periods of diagnosis 1995 – 1998 and 1999 – 2001(Figure 1). 
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Table 5: Multivariate Predictors of CRC Survival Using Cox 
Proportional Hazard Modeling 
Analysis of Maximum Likelihood Estimates 
Parameter 
Subgro
up HR 95% C.I of the HR 
Subgro
up P-
value 
  LL UL  
Race/Ethnicity 
Ref = White 
1    
Blacks 1.216 1.054 1.403 0.0073      
Asian 1.059 0.867 1.293 0.5744 
Hispanic 1.142 0.984 1.324 0.0796 
Stage 
Ref = Localized 
    
Regional 2.746 2.415 3.123 <.0001      
Distant 10.975 9.661 12.469 <.0001      
Unstaged   8.765 <.0001      
Payer 
Ref = Private 
    
Medicaid 1.191 0.943 1.503 0.1420 
Medicare 1.302 1.116 1.518 0.0008 
Uninsured 1.227 1.045 1.441 0.0127      
Unknown 1.193 1.080 1.318 0.0005 
Age Group 
Ref  = Less than 44 
    
45 – 54 1.127 0.898 1.415 0.3012      
55 – 64 1.221 0.989 1.506 0.0627      
65 – 74 1.381 1.123 1.699 0.0022      
75+ 2.002 1.630 2.458 <.0001      
 
Gender 
Ref = Male 
    
Female 0.919 0.856 0.986 0.0194 
     
Tumor sub-location 
Ref = Proximal 
    
Colon NOS 1.954 1.761 2.167 <.0001      
Rectosigmoid and Rectum 0.960 0.874 1.055 0.3935      
Sigmoid Colon 0.922 0.831 1.022 0.1207      
     
 
Type 3 Tests 
Wald 
       Group Effect   DF    Chi-Square        Group p-value 
Race/eth 5 25.1670 0.0001 
Stage 3 1798.1097 <.0001 
Gender 1 5.4650 0.0194 
Payer 4 16.8730 0.0020 
Diag Period 1 14.6261 0.0001 
Age Group 4 148.6613 <.0001 
Sub-Location            3 226.1119         <.0001 
 
 
23 
 
 
 
 
 
 
 
Figure 1: Age-Adjusted CRC Survival Rates After Five Years Compared 
Between Diagnosis Periods.  
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CHAPTER 5 
DISCUSSION 
Numerous studies have been conducted to evaluate CRC 
survival differences between African Americans and White. 
These studies showed overall poorer survival for African 
Americans compared to Whites (Ries et al, 2000; Marcella e 
t al., 2001; Govindarajan et al., 2003; Clegg et al., 
2002). 
In this study, initial univariate analysis demonstrated 
Blacks patients with CRC had significantly worse survival 
than White patients. After controlling for age groups, 
gender, period of diagnosis, sub location of the tumor, 
type of health insurance, and stage of diagnosis, these 
survival differences persisted for African Americans. In 
addition, a significant disadvantage was shown for 
Hispanics in relation to the univariate model.  
Studies (Swan et al., 2003; Cheng et al., 2001) have 
consistently reported stage at diagnosis as the strongest 
predictor of excess risk of death for CRC patients. Swan et 
al. and Cheng et al. reported in their studies that stage 
of diagnosis accounts for greater than 50 percent of the 
excess mortality.  However, this was not found in our study 
as the final model accounted for all covariates and not 
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stage of diagnosis alone. Stage of diagnosis by far was 
shown to be the strongest predictor of CRC survival 
disparity in this study. 
Certainly, besides the obvious benefits of early stage at 
diagnosis, detecting tumors earlier reduces both short-term 
and long-term morbidity and mortality by increasing the 
chances of successful curative surgeries and decreasing the 
number of treatment-related complications such as bowel 
obstruction, perforation, or excessive bleeding (Yan et 
al., 2008). Our study could not look at clinical factors 
such as surgery, or chemotherapy due to incompleteness of 
clinical information in the registry. 
Through screening, CRC can be detected at early stages 
which are also treatable. According to Swan et al. (2003) 
data from the 2000 National Health Interview Survey 
indicated that Blacks and Whites report similar rates of 
screening with either occult blood stool sampling or 
colorectal endoscopy. 
In addition, between 1987 and 2000, Cheng et al. (2001) 
reported Blacks improved their rates of screening for colon 
cancer as compared with Whites. These findings, along with 
data suggesting that Blacks present with more proximal 
tumors (Cheng et al.,2001) and at a younger age, has 
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heralded the suggestion among some experts to recommend 
that African Americans receive colonoscopies as first-line 
screening starting at age 45 (Agrawal et al.,2005). Due to 
lack of screening data in cancer database, this study could 
not analyze information about CRC screening. For future 
studies, better ways should be designed that will link 
cancer registry and other population databases that collect 
information on CRC screening. 
Furthermore, although the relatively poor outcomes 
associated with advanced stage did not account for all of 
the excess mortality experienced by Blacks and Hispanic 
patients seen in our study, we found significant 
differences in age adjusted survival rates by diagnosis 
period (Figure 1). The clinical implications of these 
findings are unavailable or/unknown, although it is 
possible that the higher mortality associated with advanced 
disease takes its full toll closer to the time of 
diagnosis, and if patients survive beyond the first few 
years of their disease, other factors such as comorbid 
diseases may make a greater contribution to mortality. 
Obviously, many prior studies have aimed at elucidating 
reasons for the noted racial disparity in CRC survival, and 
multiple factors have been implicated including differences 
27 
 
in stage at diagnosis, tumor biology, and socioeconomic 
status (SES) among others (Du et al.,2007). Although stage 
at diagnosis is consistently more advanced among Blacks CRC 
patients compared with Whites, adjustment for stage alone 
does not explain all of the racial disparity in survival 
(Roetzheim et al., 2000). These findings are also supported 
by our findings. 
Previous reports showed that African Americans diagnosed 
with colorectal cancer are more likely to reside within 
lower SES areas than their White American counterparts, 
suggesting that race may act as a proxy for the influence 
of SES on survival (Polite et al., 2006). 
Other studies (Du et al. 2007), have looked at SES as one 
of the determinant of CRC survival disparity amongst 
race/ethnicity groups. SES was not analyzed in our study. 
Additionally, it is important to note that individual SES 
is unavailable in large cancer databases such as SEER, and 
that SES has been inconsistently defined in several 
studies, being most often based on neighborhood data 
(Krieger et al., 1997). 
Moreover, marital status has also been one of the known 
determinants of colorectal cancer survival outcomes. 
Nevertheless, the relation between marital status and colon 
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cancer survival has not been completely explained, and data 
on the subject are sparse. Our data did not analyze marital 
status variable. For future improvement of this study we 
look forward to as well study marital status data in the 
cancer registry. 
Inequalities in access to and receipt of quality health 
care and/or differences in comorbidities have been 
constantly mentioned as determinants for CRC differential 
survival among race and ethnicities. This study was able to 
look at the type of health insurance at diagnosis. However, 
data quality for health insurance type was uncertain at 
best, with more than 50 percent of the patients in the 
study recorded with unknown insurance type. This can bias 
the results of the analysis specifically in predicting 
survival disparity using types of health insurance. 
Besides, this study partly compensates the problem of 
comorbidities, at least for the most fetal one, by 
considering cause-specific survival. 
Studies are inconsistent in explaining the extent to 
which factors other than stage of diagnosis contribute to 
the overall differential survival among race and 
ethnicities. Yet, some studies suggest that African 
Americans who receive cancer treatment and medical care 
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similar to that of whites experience similar outcomes 
(Ghafoor et al., 2002). For future studies, type of 
treatments can be studied to justify the persisting 
racial/ethnicity survival disparity of CRC seen in Nevada. 
In the study by Mayberry (1995), the authors found that 
Blacks were more likely than Whites to be diagnosed with 
advanced disease. After adjustment for stage, however, the 
disparity diminished. There was no racial difference in 
survival for patients with distant stage metastatic 
disease. These results substantially support the hypothesis 
that black/white differences in colon cancer survival are 
due to later stage of disease at diagnosis among Blacks. In 
this study, however, after adjustment for all covariates a 
disparity in CRC survival was found for both Blacks and 
Hispanics. 
Age at diagnosis is also an important predictor of 
survival for patients with CRC (Dominitz et al.,1998; Du et 
al.,2007; Roetzheim et al.,2000; Agrawal et al.,2005) and 
our data clearly supports this observation. 
Aging is associated with decrease in many bodily 
functions and the elderly generally do not have as much 
physical reserve to combat a serious illness such as CRC as 
do their younger counterparts (Krieger et al., 1997; 
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Rabeneck et al., 2003). In addition, proximal colon cancers 
became relatively more common as age increases and such 
tumors are less likely to be diagnosed at an early stage, 
potentially leading to increased mortality rates seen among 
older patients with CRC (Krieger et al., 1997; Rabeneck et 
al., 2003). Blacks are more likely to be diagnosed at a 
younger age than White (Swan et al., 2003), which is 
supported by our data (table 3). The implications of this 
are uncertain, but, coupled with the increased likelihood 
that Blacks have proximal colon tumors led the American 
College of Gastroenterology to recommend colonoscopy as a 
primary screening tool for colorectal cancer in African 
Americans along with starting screening at an earlier age. 
In our study, 49.8 percent (largest to all race/ethnic 
groups) of Blacks were diagnosed with proximal colon.  
In regards to treatment, age alone does not increase the 
risks associated with primary tumor resection as described 
by McGinnis (1994), and aggressive surgical options should 
be considered, regardless of age, depending on the presence 
of comorbidities. 
Furthermore, Meyerhardt ,Giovannucci and Holmes et 
al.,(2006) and Meyerhardt, Heseltine, and Niedzwiecki et 
al.,(2006) reported that low levels of physical activity 
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and the metabolic syndrome, which includes obesity, are 
associated with higher rates of CRC, decreased overall CRC 
survival, and increased rates of recurrence. Other studies 
by (Flegal et al., 2002; Kuczmarski et al., 1994) the 
authors found that Blacks are more likely to be obese and 
physically inactive than White. To what extent these and 
other comorbid conditions contribute to the excess 
mortality observed for Blacks with CRC is uncertain. Future 
studies can investigate the association of physical 
activity, obesity, and diet on CRC racial and ethnic 
survival disparities. 
Conclusion and Limitations 
This study provides an examination of survival 
disparities among individuals with CRC for the first time 
in the state of Nevada. The NCCR includes adequate number 
of race and ethnic groups which allowed for the study of 
CRC survival disparities. In addition to a large sample 
size, it allowed for a more comprehensive assessment of 
cancer-specific survival.  
There were a number of limitations experienced in the 
study including: limited follow-up time (2006) and its 
passive characteristics, as well as low quality of NCCR 
registry data with the majority of patients having unknown 
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types of insurance; also, low quality of death certificates 
in identifying cause of death, as well as the absence of a 
linkage with out-of-state deaths. All these made it 
difficult for accurate analysis of cancer survival rates.  
In summary, this study shows that while multiple factors 
may account for a decreased CRC survival, they do not 
explain the survival disparity observed between Whites and 
Blacks and Hispanics in the study. This means that in 
Nevada the effect of race and ethnicity is still present 
even when accounted for all covariates. In essence, the 
disparity related to race and ethnic group should be 
further studied with improved data on health insurance and 
treatment. 
Advanced stage at diagnosis contributed to poorer 
survival experience for all patients, especially in the 
first few years after CRC diagnosis, but other factors, 
including health insurance type, gender, tumor sub-
location, age, and diagnosis period (Cox regression model) 
were also associated with decreased survival. As lack of 
insurance severely limits one’s ability to obtain adequate 
screening opportunities and appropriate treatment, it was 
found that CRC survival disparities existed among those 
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with different types of health insurance(private versus 
Medicare), and uninsured patients.  
More aggressive screening and equal treatment 
opportunities would do much to remedy the survival 
disparity seen among Blacks and White American individuals 
with colorectal cancer. More public health intervention 
programs should focus on increasing CRC screening awareness 
as well as ensuring equal accessibility to health care and 
treatments service. Early identification of CRC cases will 
ultimately cut down incidence cases and improve survival. 
 
 
 
 
 
 
 
 
 
 
 
 
 
34 
 
APPENDIX  
IRB APPROVAL 
Biomedical IRB – Exempt Review 
Deemed Exempt 
DATE:  November 2, 2010 
TO: Dr. Paulo Pinheiro, Community Health Sciences 
FROM: Office of Research Integrity – Human Subjects  
RE: Notification of review by Dr. John Mercer, Chair 
 Protocol Title: The Determinants of Colorectal 
Cancer Survival Disparities in Nevada Protocol # 
1006-3492M 
_________________________________________________________ 
This memorandum is notification that the project referenced 
above has been as indicated in Federal regulatory statutes 
45CFR46.   
 
The protocol has been reviewed and deemed exempt from IRB 
review.  It is not in need of further review or approval by 
the IRB. 
 
Any changes to the exempt protocol may cause this project 
to require a different level of IRB review.  Should any 
changes need to be made, please submit a Modification Form. 
 
If you have questions or require any assistance, please 
contact the Office of Research Integrity – Human Subjects 
at IRB@unlv.edu or call 895-2794. 
 
35 
 
BIBLIOGRAPHY 
Agrawal, S., Bhupinderjit, A., Bhutani, M. S., Boardman, 
L., Nguyen, C., Romero, Y., Srinvasan, R., Figueroa-
Moseley, C., & Hamilton, F. A. (2005). Colorectal cancer 
in african americans. American Journal of 
Gastroenterology, 100(3), 515-523. doi:10.1111/j.1572-
0241.2005.41829.x  
Altekruse, S. F., Kosary, C. L., Krapcho, M., Neyman, N., 
Aminou, R., Waldron, W., Ruhl, J., Howlader, N., 
Tatalovich, Z., Cho, H., Mariotto, A., Eisner, M. P., 
Lewis, D. R., Cronin, K., Chen, H. S., Feuer, E. J., 
Stinchcomb, D. G. & Edwards, B. K. (2010). SEER cancer 
statistics review, 1975-2007. Retrieved November, 2010, 
from http://seer.cancer.gov/csr/1975_2007/  
Ayanian, J. Z., Kohler, B. A., Abe, T., & Epstein, A. M. 
(1993). The relation between health insurance coverage 
and clinical outcomes among women with breast cancer. 
New England Journal of Medicine, 329(5), 326-331. 
doi:10.1056/NEJM199307293290507  
Bach, P. B., Schrag, D., Brawley, O. W., Galaznik, A., 
Yakren, S., & Begg, C. B. (2002). Survival of blacks and 
whites after a cancer diagnosis. Journal of the American 
Medical Association, 287(16), 2106-2113.  
Chengwu, X., Chen, V. W., Steele, B., Ruiz, B., Fulton, J., 
Liu, L., Carozza, S. E., & Greenlee, R. (2001). Subsite-
specific incidence rate and stage of disease in 
colorectal cancer by race, gender, and age group in the 
united states, 1992-1997. Cancer, 92(10), 2547-2554. 
doi:10.1002/1097-0142(20011115)92:10<2547::AID-
CNCR1606>3.0.CO;2-K  
Clegg, L. X., Li, F. P., Hankey, B. F., Chu, K., & Edwards, 
B. K. (2002). Cancer survival among US whites and 
minorities: A SEER (surveillance, epidemiology, and end 
results) program population-based study. Archives of 
36 
 
Internal Medicine, 162(17), 1985-1993. 
doi:10.1001/archinte.162.17.1985  
Dominitz, J. A., Samsa, G. P., Landsman, P., & Provenzale, 
D. (1998). Race, treatment, and survival among 
colorectal carcinoma patients in an equal-access medical 
system. Cancer, 82(12), 2312-2320. 
doi:10.1002/(SICI)1097-0142(19980615)82:12<2312::AID-
CNCR3>3.0.CO;2-U  
Du, X. L., Meyer, T. E., & Franzini, L. (2007). Meta-
analysis of racial disparities in survival in 
association with socioeconomic status among men and 
women with colon cancer. Cancer, 109(11), 2161-2170. 
doi:10.1002/cncr.22664  
Espey, D. K., Wu, X. -., Swan, J., Wiggins, C., Jim, M. A., 
Ward, E., Wingo, P. A., Howe, H. L., Ries, L. A. G., 
Miller, B. A., Jemal, A., Ahmed, F., Cobb, N., Kaur, J. 
S., & Edwards, B. K. (2007). Annual report to the nation 
on the status of cancer, 1975-2004, featuring cancer in 
american indians and alaska natives. Cancer, 110(10), 
2119-2152. doi:10.1002/cncr.23044  
Etzioni, D. A., Yano, E. M., Rubenstein, L. V., Lee, M. L., 
Ko, C. Y., Brook, R. H., Parkerton, P. H., & Asch, S. M. 
(2006). Measuring the quality of colorectal cancer 
screening: The importance of follow-up. Diseases of the 
Colon and Rectum, 49(7), 1002-1010. doi:10.1007/s10350-
006-0533-2  
Flegal, K. M., Carroll, M. D., Ogden, C. L., & Johnson, C. 
L. (2002). Prevalence and trends in obesity among US 
adults, 1999-2000. Journal of the American Medical 
Association, 288(14), 1723-1727.  
Ghafoor, A., Jemal, A., Cokkinides, V., Cardinez, C., 
Murray, T., Samuels, A., & Thun, M. J. (2002). Cancer 
statistics for african americans. Ca-A Cancer Journal 
for Clinicians, 52(6), 326-341.  
37 
 
Govindarajan, R., Shah, R. V., Erkman, L. G., & Hutchins, 
L. F. (2003). Racial differences in the outcome of 
patients with colorectal carcinoma. Cancer, 97(2), 493-
498. doi:10.1002/cncr.11067  
James, A. S., Campbell, M. K., & Hudson, M. A. (2002). 
Perceived barriers and benefits to colon cancer 
screening among african americans in north carolina: How 
does perception relate to screening behavior? Cancer 
Epidemiology Biomarkers and Prevention, 11(6), 529-534.  
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., 
& Thun, M. J. (2003). Cancer statistics, 2003. Ca-A 
Cancer Journal for Clinicians, 53(1), 5-26.  
Krieger, N. (1999). Social class, race/ethnicity, and 
incidence of breast, cervix, colon, lung, and prostate 
cancer among asian, black, hispanic, and white residents 
of the san francisco bay area, 1988-92 (united states). 
Cancer Causes and Control, 10(6), 525-537.  
Kuczmarski, R. J., Flegal, K. M., Campbell, S. M., & 
Johnson, C. L. (1994). Increasing prevalence of 
overweight among US adults: The national health and 
nutrition examination surveys, 1960 to 1991. Journal of 
the American Medical Association, 272(3), 205-211. 
doi:10.1001/jama.272.3.205  
Lawsin, C., DuHamel, K., Weiss, A., Rakowski, W., & 
Jandorf, L. (2007). Colorectal cancer screening among 
low-income african americans in east harlem: A 
theoretical approach to understanding barriers and 
promoters to screening. Journal of Urban Health, 84(1), 
32-44. doi:10.1007/s11524-006-9126-6  
Marcella, S., & Miller, J. E. (2001). Racial differences in 
colorectal cancer mortality: The importance of stage and 
socioeconomic status. Journal of Clinical Epidemiology, 
54(4), 359-366. doi:10.1016/S0895-4356(00)00316-4  
38 
 
Mayberry, R. M., Coates, R. J., Hill, H. A., Click, L. A., 
Chen, V. W., Austin, D. F., Redmond, C. K., Fenoglio-
Preiser, C. M., Hunter, C. P., Haynes, M. A., Muss, H. 
B., Wesley, M. N., Greenberg, R. S., & Edwards, B. K. 
(1995). Determinants of black/white differences in colon 
cancer survival. Journal of the National Cancer 
Institute, 87(22), 1686-1693.  
McGinnis, L. S. (1994). Surgical treatment options for 
colorectal cancer. Cancer, 74(7 SUPPL.), 2147-2150.  
Meyerhardt, J. A., Giovannucci, E. L., Holmes, M. D., Chan, 
A. T., Chan, J. A., Colditz, G. A., & Fuchs, C. S. 
(2006). Physical activity and survival after colorectal 
cancer diagnosis. Journal of Clinical Oncology, 24(22), 
3527-3534. doi:10.1200/JCO.2006.06.0855  
Meyerhardt, J. A., Heseltine, D., Niedzwiecki, D., Hollis, 
D., Saltz, L. B., Mayer, R. J., Thomas, J., Nelson, H., 
Whittom, R., Hantel, A., Schilsky, R. L., & Fuchs, C. S. 
(2006). Impact of physical activity on cancer recurrence 
and survival in patients with stage III colon cancer: 
Findings from CALGB 89803. Journal of Clinical Oncology, 
24(22), 3535-3541. doi:10.1200/JCO.2006.06.0863  
Mostafa, G., Matthews, B. D., Norton, H. J., Kercher, K. 
W., Sing, R. F., & Heniford, B. T. (2004). Influence of 
demographics on colorectal cancer. American Surgeon, 
70(3), 259-264.  
Nelson, A. (2002). Unequal treatment: Confronting racial 
and ethnic disparities in health care. Journal of the 
National Medical Association, 94(8), 666-668.  
Peterson, N. B., Murff, H. J., Fowke, J. H., Cui, Y., 
Hargreaves, M., Signorello, L. B., & Blot, W. J. (2008). 
Use of colonoscopy and flexible sigmoidoscopy among 
african americans and whites in a low-income population. 
Preventing Chronic Disease, 5(1)  
39 
 
Polite, B. N., Dignam, J. J., & Olopade, O. I. (2006). 
Colorectal cancer model of health disparities: 
Understanding mortality differences in minority 
populations. Journal of Clinical Oncology, 24(14), 2179-
2187. doi:10.1200/JCO.2005.05.4775  
Rabeneck, L., Davila, J. A., & El-Serag, H. B. (2003). Is 
there a true "shift" to the right colon in the incidence 
of colorectal cancer? American Journal of 
Gastroenterology, 98(6), 1400-1409. doi:10.1016/S0002-
9270(03)00227-2  
Rabeneck, L., El-Serag, H. B., Davila, J. A., & Sandler, R. 
S. (2003). Outcomes of colorectal cancer in the united 
states: No change in survival (1986-1997). American 
Journal of Gastroenterology, 98(2), 471-477. 
doi:10.1016/S0002-9270(02)05928-2  
Ries, L. A. G., Wingo, P. A., Miller, D. S., Howe, H. L., 
Weir, H. K., Rosenberg, H. M., Vernon, S. W., Cronin, 
K., & Edwards, B. K. (2000). The annual report to the 
nation on the status of cancer, 1973-1997, with a 
special section on colorectal cancer. Cancer, 88(10), 
2398-2424.Vdoi:10.1002/(SICI)1097-
0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I  
Robbins, A. S., Pavluck, A. L., Fedewa, S. A., Chen, A. Y., 
& Ward, E. M. (2009). Insurance status, comorbidity 
level, and survival among colorectal cancer patients age 
18 to 64 years in the national cancer data base from 
2003 to 2005. Journal of Clinical Oncology, 27(22), 
3627-3633. doi:10.1200/JCO.2008.20.8025  
Roetzheim, R. G., Pal, N., Gonzalez, E. C., Ferrante, J. 
M., Van Durme, D. J., & Krischer, J. P. (2000). Effects 
of health insurance and race on colorectal cancer 
treatments and outcomes. American Journal of Public 
Health, 90(11), 1746-1754.  
Schroy III, P. C., Glick, J. T., Robinson, P. A., Lydotes, 
M. A., Evans, S. R., & Emmons, K. M. (2008). Has the 
40 
 
surge in media attention increased public awareness 
about colorectal cancer and screening? Journal of 
Community Health, 33(1), 1-9. doi:10.1007/s10900-007-
9065-5  
Swan, J., Breen, N., Coates, R. J., Rimer, B. K., & Lee, N. 
C. (2003). Progress in cancer screening practices in the 
united states: Results from the 2000 national health 
interview survey. Cancer, 97(6), 1528-1540. 
doi:10.1002/cncr.11208  
U.S Cancer Statistics Working Group. (2010). United states 
cancer statistics: 1999–2006 incidence and mortality 
web-based report. Retrieved November, 2010, from 
www.cdc.gov/uscs  
Walsh, J. M. E., & Terdiman, J. P. (2003). Colorectal 
cancer screening: Scientific review. Journal of the 
American Medical Association, 289(10), 1288-1296. 
doi:10.1001/jama.289.10.1288  
Ward, E., Jemal, A., Cokkinides, V., Singh, G. K., 
Cardinez, C., Ghafoor, A., & Thun, M. (2004). Cancer 
disparities by race/ethnicity and socioeconomic status. 
Ca-A Cancer Journal for Clinicians, 54(2), 78-93.  
World Health Organization. (1990). International 
classification of diseases for oncology (2nd ed.). 
Geneva, Switzerland: World Health Organization.  
Yan, B., Noone, A., Yee, C., Banerjee, M., Schwartz, K., & 
Simon, M. S. (2009). Racial differences in colorectal 
cancer survival in the detroit metropolitan area. 
Cancer, 115(16), 3791-3800. doi:10.1002/cncr.24408  
41 
 
VITA 
Graduate College 
University of Nevada, Las Vegas 
 
Lucas N. Wassira 
Degree: 
 Bachelor of Arts, Medical Sociology 
 University of Dar es Salaam, Tanzania 
 
Special Honors and Awards: 
 James F. Adams/GPSA Scholarship, 2010 
 
Thesis Title: The Determinants of Colorectal Cancer  
  Survival Disparities in Nevada 
 
Thesis Examination Committee: 
 Chairperson, Paulo Pinheiro, MD Ph.D. 
 Committee Member, James Symanowski, Ph.D. 
 Committee Member, Michelle Chino, Ph.D. 
 Committee Member, Sheniz Moonie, Ph.D. 
 Graduate Faculty Representative, Patricia Alpert, 
 Dr.PH. 
